<!doctype html>
<html>
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width">
<title></title>
<link rel="stylesheet" href="css/style.css">
</head>

<body>

<header>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <p class="title"><a href="index.html">社外秘 研修資料</a></p>
  <div class="r"><a href="247.html"><span>right</span></a></div>
</header>

<div class="wrap">
  <div class="clearfix">
  <img src="img04/multi.png" alt="マルチスタジオ非掲載" width="110" height="20" style="float: right;">
</div>
  <section>
    <h1 class="tit">2ndBioは作用機序を変えた方が継続率が高い</h1>
  </section>
  <section>
    <p class="txt"><strong>201名の2nd line biologics患者についてTNF cyclingと別のMOA薬剤に切り替えた群で継続率を評価</strong></p>
    <div class="img"><img src="img/196-1.png" alt=""></div>
    <div class="img"><img src="img/196-2.png" alt=""></div>
    <div class="img"><img src="img/196-3.png" alt=""></div>
    <div class="greenbox"><p><strong>TNF→TNFのスイッチよりも、別のMOAに変えた方が、効果不十分、有害事象による脱落が少なく、継続率が高い</strong></p></div>
    <p class="txt sml right"><a href="http://maps.ty.chugai-pharm.co.jp/Search/Detail.aspx?id=E21678&skey=d7f7671b-3cc7-49fc-81d2-086890aac90d">Ennio Giulio Favalli, et al. Rheumatology 2014;53:16641668</a></p>
  </section>
</div>

<footer>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <div class="home"><a href="index.html"><span>HOME</span></a></div>
  <div class="r"><a href="247.html"><span>right</span></a></div>
  <div class="pagetop"><a href="javascript:scroll(0,0);">pagetop</a></div>
</footer>

<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.2/jquery.min.js"></script>
<script src="js/common.js"></script>
</body>
</html>
